We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$642M
AUM Growth
-$101M
Cap. Flow
+$10.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
82.26%
Holding
47
New
2
Increased
7
Reduced
21
Closed
2

Top Sells

Rank Stock Value
1
AGO icon
Assured Guaranty
AGO
+$2.81M
2
PTEN icon
Patterson-UTI
PTEN
+$2.67M
3
MRK icon
Merck
MRK
+$1.32M
4
BP icon
BP
BP
+$811K
5
XOM icon
ExxonMobil
XOM
+$666K

Sector Composition

Rank Sector Weight
1 Healthcare 34.75%
2 Financials 32.99%
3 Energy 18.33%
4 Consumer Staples 5.33%
5 Technology 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$65.7M 10.24%
924,093
-4,772
-0.5% -$346K
BP icon
2
BP
BP
$106B
$62.1M 9.67%
2,173,723
-27,256
-1% -$811K
AGO icon
3
Assured Guaranty
AGO
$3.73B
$60.4M 9.41%
1,252,676
-52,322
-4% -$2.81M
MRK icon
4
Merck
MRK
$315B
$58.6M 9.13%
684,255
-14,769
-2% -$1.32M
PTEN icon
5
Patterson-UTI
PTEN
$3.66B
$53.8M 8.38%
4,603,562
-186,805
-4% -$2.67M
FLG
6
Flagstar Bank National Association
FLG
$6.4B
$50.6M 7.89%
1,979,038
+38,246
+2% +$1.12M
C icon
7
Citigroup
C
$221B
$48.5M 7.55%
1,162,791
+47,993
+4% +$2.37M
PFE icon
8
Pfizer
PFE
$143B
$45.6M 7.11%
1,042,353
-5,146
-0.5% -$250K
MBI icon
9
MBIA
MBI
$328M
$44.3M 6.9%
4,810,474
-25,930
-0.5% -$307K
GSK icon
10
GSK
GSK
$106B
$38.4M 5.98%
1,304,939
+160,011
+14% +$6.06M
SEB icon
11
Seaboard Corp
SEB
$4.4B
$33.5M 5.23%
9,857
-51
-0.5% -$197K
VOXX
12
DELISTED
VOXX International Corporation Class A
VOXX
$22.4M 3.49%
2,942,172
+266,160
+10% +$2.29M
IDT icon
13
IDT Corp
IDT
$1.58B
$11.6M 1.81%
467,829
-337
-0.1% -$8.66K
HLN icon
14
Haleon
HLN
$44.5B
$8.79M 1.37%
+1,442,550
New +$9.34M
BB icon
15
BlackBerry
BB
$5.37B
$6.94M 1.08%
1,476,968
-21,760
-1% -$130K
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
$6.02M 0.94%
1,653,417
+30,000
+2% +$101K
WBS icon
17
Webster Financial
WBS
$12.4B
$5.18M 0.81%
114,564
-7,164
-6% -$332K
GNE icon
18
Genie Energy
GNE
$378M
$3.02M 0.47%
322,777
-337
-0.1% -$3.26K
HOLX
19
DELISTED
Hologic
HOLX
$2.06M 0.32%
31,985
NVS icon
20
Novartis
NVS
$291B
$1.75M 0.27%
23,078
OGN icon
21
Organon & Co
OGN
$3.54B
$1.46M 0.23%
62,268
-4,290
-6% -$130K
XOM icon
22
ExxonMobil
XOM
$605B
$1.3M 0.2%
14,909
-7,300
-33% -$666K
TPHS
23
DELISTED
Trinity Place Holdings Inc.com
TPHS
$1.29M 0.2%
1,457,260
-7,347
-0.5% -$7.44K
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
$830K 0.13%
3,107
-43
-1% -$12.2K
VTRS icon
25
Viatris
VTRS
$20.2B
$637K 0.1%
74,462
-747
-1% -$7.35K

Similar funds

Kahn Brothers Group's Q3 2022 Portfolio in Review

As of Q3 2022, Kahn Brothers Group held 47 positions worth $642M, down 14% from $743M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Kahn Brothers Group's Q3 2022 filing shows 2 new, 7 increased, 21 reduced and 2 closed positions. Its largest new stake was Haleon: 1,442,550 shares worth $8.79M. The largest sale was Assured Guaranty, an estimated $2.81M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 35% a quarter earlier, followed by Financials and Energy.

  • Kahn Brothers Group's largest Q3 2022 buy was Haleon: 1,442,550 shares worth $8.79M.
  • Kahn Brothers Group added most to GSK in Q3 2022, an estimated $6.06M increase.
  • Kahn Brothers Group's biggest Q3 2022 reduction was Assured Guaranty, cutting an estimated $2.81M.
  • Kahn Brothers Group fully exited Nam Tai Property Inc. in Q3 2022, selling an estimated $364K.
  • Kahn Brothers Group's ten largest holdings make up 82% of its $642M portfolio in Q3 2022.
  • Kahn Brothers Group opened 2 new positions and closed 2 in Q3 2022.
  • Kahn Brothers Group's portfolio value fell 14% quarter-over-quarter to $642M.

Based on Kahn Brothers Group's 13F filing for Q3 2022, filed 15 Nov 2022.